SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MAXY - Maxygen, Inc.
An SI Board Since December 1999
Posts SubjectMarks Bans Symbol
262 30 0 MAXY
Emcee:  westpacific Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
262Wow—that was 1.8 years on this board without a post! Not much going on at MAXY tDewDiligence_on_SI-4/22/2010
261NEW YORK, April 21 (Reuters) - U.S. biotech company Codexis Inc priced shares innigel bates-4/22/2010
260Bayer Licenses Maxygen’s FVIIa Analog: siliconinvestor.com This deal, which inDewDiligence_on_SI-7/2/2008
259UPDATE 2-Maxygen says drug under Amgen patent cloud; shares sink Fri Jun 13, 200kenhott-6/16/2008
258[Maxygen Partner Ends Hepatitis C Program] <i>Last nail in this coffin.<tnsaf-11/26/2007
257You can't take random board postings too seriously. I am not sure at all thkenhott-9/21/2007
256Musings on MAXY and GTCB: siliconinvestor.comDewDiligence_on_SI-9/21/2007
255hgsi albuferon I think is kind of so so but will probably do ok. Biolex/Octoplusrkrw-9/21/2007
254The remaining promising one's coming to my mind are Biolex, HGSI n Intarcia dr.praveen-9/21/2007
253Message 23367983 You might conclude I'm stoopid or just dense. You wouldn&keokalani'nui-9/21/2007
252They did one thing right. They raised a boatload of money during Mr. Bub, so itkeokalani'nui-9/21/2007
251<I'd say we're the last to know. ...> <I'll wait for a reckenhott-9/21/2007
250Now officially nothing from their vaunted gene shuffling platform is in the clinrkrw-9/21/2007
249Only down 15% on 500k--I'd say we're the last to know. For that and fkeokalani'nui-9/21/2007
248Another one goes down. Press Release Source: Maxygen, Inc Maxygen Announces rkrw-9/21/2007
247Maxygen Initiates Phase IIa Clinical Trial of MAXY-G34 in Breast Cancer Patientsnigel bates-7/2/2007
246Maxy had decided to advance MAXY-VII into hemophilia on its own with an IND targdr.praveen-6/19/2007
245Very smart of Novo to lock up next gen formulations. Make collaborators think twrkrw-6/15/2007
244NVO’s NN1731 is further along in development.DewDiligence_on_SI-6/15/2007
243Novo thinks there's potential for a next gen factor VIIa... Press Release Srkrw-6/15/2007
242And another.... CoGenesys Expands Clinical Programs with Initiation of Phase 1-rkrw-3/27/2007
241More than an unmet need, I would say an unrecognized opp:-) biz.yahoo.comdr.praveen-3/26/2007
240Roche giving it back as soon as Novoseven failed in ICH supports your thoughts. dr.praveen-3/26/2007
239And you never know, roche giving it back could turn out to be a good thing. Peoprkrw-3/25/2007
238Thanks! Looks like a contender (G34), but I can't really tell if there is ikeokalani'nui-3/22/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News